As SpaceX Falls Down to Earth, the Stock Is Still Not a Buy

SpaceX has already fallen back to its first-day trading levels after debuting and now faces 15 lock-up expirations over the next year-plus, including 911.5 million shares eligible to sell after the first earnings release and another 319 million shares on Aug. 20. The article argues the stock’s $2 trillion valuation is heavily dependent on speculative moonshot bets, including space-based AI data centers and a Tesla-Intel chip plant, making the shares vulnerable despite strong long-term ambitions.

Analysis

The near-term setup is less about fundamental deterioration than about a classic post-IPO supply overhang colliding with a tiny initial float. When a name is priced for scarcity and narrative optionality, every scheduled unlock becomes a mini secondary offering; that usually compresses multiple before it changes the business. In practice, the first few unlock windows matter most because they re-anchor price discovery and can reset momentum from “must-own” to “wait for supply absorption.”

The bigger second-order risk is that the market is currently paying equity-like upfront for a bundle of highly uncertain venture-stage options. That creates a valuation structure where the core operating assets need to justify a large portion of enterprise value on their own, but the stock is being marketed on projects with long-dated, binary payoff distributions. If capital markets tighten or if one flagship moonshot slips by even 12-18 months, the discount rate on the entire story rises and the implied value of the optionality collapses disproportionately.

There is also an industry read-through here: the public comps most exposed are the “enabling picks-and-shovels” tied to launch, satellite, advanced compute, and frontier manufacturing rather than the issuer itself. If investors rotate out of the headline name after unlocks, that capital may not leave the theme entirely; it can migrate into lower-beta beneficiaries with nearer-term cash flows and clearer monetization paths. That favors the ecosystem over the parent story, especially while the market is still willing to underwrite the AI/space narrative in smaller, more digestible pieces.

Contrarian takeaway: the consensus may be underestimating how quickly scarcity premium can vanish once supply becomes tradable, but also overestimating how much of the current price truly depends on the moonshots. If the stock can absorb the first two unlocks without breaking prior lows, the bear case weakens materially; if it cannot, the technical damage likely persists for months rather than days because each subsequent unlock becomes an event-driven cap on upside.

Key Decisions for Investors

• Avoid initiating long exposure in SPCX into the first two unlock windows; wait for post-unlock price/volume stabilization over 2-4 weeks, since the risk/reward is skewed toward a 10-20% air pocket versus limited near-term upside.
• If able to trade options, consider a defined-risk bearish structure on SPCX into earnings/unlock catalysts (e.g., put spread 1-3 months out) to express view that supply overhang will keep a lid on multiple expansion; size for event volatility rather than directional certainty.
• Relative-value idea: long MORN or another cash-flowing information/services name versus short SPCX on a beta-adjusted basis; the trade benefits if investors rotate from story-driven, supply-constrained names into assets with visible monetization and lower unlock risk.
• Overweight the ecosystem, not the headline, by looking for pullbacks in NVDA/TSLA only on company-specific weakness rather than thematic sympathy; the better risk/reward may be in suppliers and beneficiaries with nearer-term earnings, not the primary narrative stock.
• Set a tactical trigger: if SPCX holds above its first post-unlock low for two consecutive weeks with declining volume, cover shorts/reduce bearish exposure; that would signal the market has absorbed supply faster than expected and the trade is no longer asymmetric.